v3.25.2
Schedule of Stock Options Issued and Outstanding Activities (Details) (Paranthetical) - shares
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Stock option grants [1] 1,471,000  
Outside of 2018 Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Stock option grants 523,300 523,300
[1] Stock options granted under the Lucid Diagnostics 2018 Equity Plan and those granted outside such plan generally vest one-third in one year then ratably over the next eight quarters, and have a ten-year contractual term from date-of-grant.